PSS5 The Cost-Effectiveness of Dexamethasone Intravitreal Implant Versus Anti-Vascular Endothelial Growth Factor Therapies for Eyes with a Phakic Lens in UK Clinical Practice
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.1106
https://www.valueinhealthjournal.com/article/S1098-3015(21)01323-1/fulltext
Title :
PSS5 The Cost-Effectiveness of Dexamethasone Intravitreal Implant Versus Anti-Vascular Endothelial Growth Factor Therapies for Eyes with a Phakic Lens in UK Clinical Practice
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01323-1&doi=10.1016/j.jval.2021.04.1106
First page :
Section Title :
Open access? :
No
Section Order :
10601